about
Renal denervation - current evidence and perspectivesPlasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.Renal artery stenosis in patients with resistant hypertension.Adrenomedullin concentrations at two time points following myocardial infarction and prediction of mid-term outcomes.Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytomaActivation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.Mediastinal paragangliomas related to SDHx gene mutations.Evaluation of Head and Neck Paragangliomas by Computed Tomography in Patients with Pheochromocytoma-Paraganglioma Syndromes.Forty-two-year-old female patient with resistant hypertension, bilateral renal fibromuscular dysplasia and intracranial aneurysm.Cardiovascular manifestations of phaeochromocytoma.Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.Primary aldosteronism - recent progress and current concepts.Cardiovascular Risk in Primary Hyperaldosteronism.Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas.Adrenal incidentaloma in adults - management recommendations by the Polish Society of Endocrinology.Carotid intima-media thickness as a marker of cardiovascular risk in hypertensive patients with coronary artery disease.Relationship between gender and clinical characteristics, associated factors, and hypertension treatment in patients with resistant hypertension.Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study.Hypertension in patients with Alzheimer's disease--prevalence, characteristics, and impact on clinical outcome. Experience of one neurology center in Poland.A registry-based study of thyroid paraganglioma: histological and genetic characteristics.Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease.Renal denervation after the symplicity HTN-3 trial.Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.Factors associated with diastolic dysfunction in patients with resistant hypertension: resist-POL study.Dopamine and dopa urinary excretion in patients with pheochromocytoma--diagnostic implications.Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.Decreased plasma concentration of a novel anti-inflammatory protein--adiponectin--in hypertensive men with coronary artery disease.Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension.Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites.On the nature of heart rate variability in a breathing normal subject: a stochastic process analysis.Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation.Independent association of obstructive sleep apnea with left ventricular geometry and systolic function in resistant hypertension: the RESIST-POL study.Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
P50
Q26829943-F1859EEB-4AE6-4C34-8B81-37C653663D83Q33846427-FD07BD08-036F-4D85-80D8-18B58F7A43D5Q34378370-D7B12769-897C-4583-B8DA-93A0B9D0D9BCQ35691363-DF4BAE4A-9921-408B-8314-EACDB5D53950Q36467102-B1625801-EBCB-46EC-8835-41CED46A8D13Q36989415-580B1804-CE77-40C6-9A42-5A496FB5E5C8Q37352164-6CF0A37B-99F5-4FFE-B67C-C76A8B439189Q37403954-B9E7D49A-D995-43DC-91C1-109FF17FE77CQ37463844-AA8EE802-4FEB-4ECF-91AA-D57053E58C7BQ37913950-59B6CE5A-8BB1-4CCA-AF32-C8B4D0BF1831Q37986699-5E146715-D7D3-4341-A43F-17AE7B3C8BCBQ38134054-8ED92DF8-99A1-46D1-8DCC-D8654B9DA642Q38635351-1FD61974-566B-4E85-8527-CFF6C3389083Q38675419-B22F1872-6C42-42BE-96F9-DB52A496FBC2Q38890111-BE231865-9988-42F4-94B0-6D1E7D9BFEADQ39134724-B572BB3E-2045-4E95-BA3A-E0D7A2F82AF1Q39848497-12AE5E9C-69CB-4625-87F9-AC9AB671C5FFQ40169100-4266CF98-DAAA-4E20-9F3E-27BB29C58FAEQ40354734-684C1F9C-DE30-4838-8283-B30B5CEF3C98Q41196983-B2ECCE06-19AF-4BC1-81D8-504DA7649FECQ41547879-1877A1F4-A39F-4A57-892D-B1C8743B6A1BQ41572822-BBD1FD32-B9A4-43D7-A26C-7BB0212CF680Q41984015-89E97C3D-F8FA-48E5-BF4F-983F69BF50A4Q42040931-D44157E5-37D7-4D4F-911D-1EBC00291524Q43047894-8B89AD34-EF4B-4B15-8309-67208FB06FA2Q43835968-7C199202-B0D7-4B06-AC84-53A6CB404942Q43859851-40277D22-76C8-412A-9681-8851E588CF04Q43988472-E1FA5EF5-FDD1-453A-9E16-3ACD622F45FBQ44207886-DD9CF9F2-F36A-4B6E-A26E-B5D4AD52B505Q44638798-BB9D4C40-CFE8-4840-BF2F-61149796B1A7Q44672012-1CB9AF61-E8B4-4D88-A53D-D13F98D1BEADQ44777212-EC3F9859-F8DC-43B9-9E9C-241537C82251Q46613736-3B732D50-FC50-46AC-8BD5-E9B7B102B865Q46718146-C1085D02-C6C1-4C45-AFF9-391D4E858654Q46796255-F342BBE4-44FD-419B-A8FA-73EB9622A29DQ46849301-EE1FD032-76D5-437D-8F4E-6F88CB139C7FQ47372984-AC88001E-9626-425B-A4F7-A7E9BCF31A66Q47574346-4221181F-6C01-43E3-BA02-E9FDC21D39AFQ47764622-C552105A-7837-4754-BDAA-590812049BBBQ47801615-4E63012C-DD71-4F56-83E8-E3E04BE6FB17
P50
description
Pools onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aleksander Prejbisz
@ast
Aleksander Prejbisz
@en
Aleksander Prejbisz
@es
Aleksander Prejbisz
@ga
Aleksander Prejbisz
@nl
Aleksander Prejbisz
@pl
Aleksander Prejbisz
@sl
type
label
Aleksander Prejbisz
@ast
Aleksander Prejbisz
@en
Aleksander Prejbisz
@es
Aleksander Prejbisz
@ga
Aleksander Prejbisz
@nl
Aleksander Prejbisz
@pl
Aleksander Prejbisz
@sl
altLabel
Aleksander Stanisław Prejbisz
@pl
prefLabel
Aleksander Prejbisz
@ast
Aleksander Prejbisz
@en
Aleksander Prejbisz
@es
Aleksander Prejbisz
@ga
Aleksander Prejbisz
@nl
Aleksander Prejbisz
@pl
Aleksander Prejbisz
@sl
P106
P1153
6602179118
P1412
P21
P27
P31
P3124
P496
0000-0001-7085-0244